Webinar | Proton Therapy| May 31, 2016

Webinar: Expanding Oncology Services With Proton Therapy

This webinar is sponsored by IBA

proton therapy, IBA, proteusPlus

This one-hour webinar explains how a community hospital, Willis-Knighton Health Systems, established a proton therapy center in less than 13 months. The Willis-Knighton Proton Therapy Center, adjacent to the hospital's existing cancer center, allows for economies of scale and continuity of care, and contains the world's first compact pencil-beam scanning proton therapy system. Experts who set up the Willis-Knighton Proton Therapy Center explains the clinical benefits of proton therapy and how it can potentially expand oncology services.

This webinar took place Thursday, June 30. 

Access the archived version of this webinar

 

Presenters

Lane Rosen, M.D., medical director of radiation oncology, Willis-Knighton Health System, Shreveport, La., is board certified (American Board Radiology). He has special interests in female malignancies, TomoTherapy, treatment of previously irradiated tumors, high dose rate (HDR) brachytherapy, and intensity modulated proton therapy (IMPT). A fifth-generation Shreveport native, Rosen is a member of the Shreveport Medical Society, Louisiana State Medical Society, the American Medical Association, the Association of Residents in Radiation Oncology (residency), the American Society of Therapeutic Radiology and Oncology, the American College of Radiation Oncology, and the Society of Neuro-Oncology.

 

Greg Sonnenfeld, director, Willis-Knighton Cancer Center – Willis-Knighton Health System, has been in healthcare for more than 15 years. He was instrumental in the development, construction and operation of the Willis-Knighton Proton Therapy Center and has led the oncology team to tremendous growth in the past seven years. Sonnenfeld has spoken on proton therapy at numerous symposiums and is an expert on proton therapy in the community hospital setting.

 

 

Mary Elizabeth (Beth) Klein, president, IBA Proton Therapy North America, is a tenured healthcare executive responsible for leading IBA’s Proton Therapy business in North America. Prior to joining IBA in 2009, she spent 27 years at GE Healthcare in sales, marketing and product development in CT, MR and ultrasound. She led GE’s unprecedented growth in nuclear imaging and PET as the global general manager for that business, and completed her tenure at GE Healthcare as the president and CEO of the Americas. She was also the commercial executive at TomoTherapy responsible for its orders ramp in 2005-2007 and played a key role in its public offering. Beth is passionately committed to growing proton therapy as a important tool in delivering more effective cancer treatments for patients.

 

 

About IBA

IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer to the medical communities and their patients. The company is the worldwide technology leader in the field of proton therapy, the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single-room systems. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,200 people worldwide, IBA is listed on the Pan-European stock exchange EURONEXT. (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB) More information can be found at: www.iba-worldwide.com. 

About Willis-Knighton Medical Center

Founded in 1924 as Tri-State Sanitarium in Shreveport, La., Willis-Knighton Medical Center was renamed in 1950 to honor the two physicians who purchased the hospital and transitioned it to a not-for-profit healthcare organization. Today, it encompasses multiple facilities, including four hospitals, a full range of support services, and a retirement community. It spans the entire continuum of care for residents in northwest Louisiana and the Ark-La-Tex area. Willis-Knighton was the first private hospital in the state to team with a public, academic medical center, Louisiana Health Sciences Center in Shreveport, on collaborative ventures. Great strides in cancer care have been made at the Willis-Knighton Cancer Center, one of the first in the world to introduce TomoTherapy image-guided radiation therapy. As a locally owned, locally operated healthcare organization, Willis-Knighton supports continuing efforts to enhance Shreveport’s position as a hub of healthcare excellence.

 

Access the archived version of this webinar

Related Content

Elekta and Brainlab Offer Streamlined Workflow for Stereotactic Radiotherapy
News | Radiation Therapy | October 16, 2017
Elekta and Brainlab have reconfirmed their alliance for the integrated use of the Elekta Versa HD linear accelerator...
National Breast Center Founder Names Top Three Innovations in Breast Cancer Treatment
News | Women's Health | October 11, 2017
In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the...
CyberKnife System Provides Excellent Long-Term Control of Low-Risk Prostate Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | October 10, 2017
Accuray Inc. announced that data from a prospective study of 230 men with low-risk prostate cancer showed 98.4 percent...
News | Image Guided Radiation Therapy (IGRT) | October 10, 2017
Elekta announced that members of the Elekta MR-linac Consortium reported data related to the advancement of the company...
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
David Beyer, M.D., chairman of the board for the American Society of Radiation Oncology (ASTRO), discusses the key th
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
Benjamin Movsas, M.D., chair of the American Society for Radiation Oncology (ASTRO) Scientific Committee, explains ho
News | Brachytherapy Systems | October 05, 2017
External researchers presented new clinical data supporting the use of iCAD’s Xoft Axxent Electronic Brachytherapy (eBx...
MedLever Showcases Radiation Oncology Applications at ASTRO 2017
News | Radiation Therapy | October 05, 2017
MedLever demonstrated its flagship platform and applications that simplify clinical workflow, enable interoperability,...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
International Trial Confirms Safety, Effectiveness of High-Dose Brachytherapy Plus Pelvic Radiation for Cervical Cancer
News | Brachytherapy Systems, Women's Healthcare | October 04, 2017
Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy or...
Overlay Init